{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:19:31Z","timestamp":1789888771492,"version":"4.0.1"},"reference-count":120,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Septic shock is a significant challenge in the management of patients with burns and traumatic injuries when complicated by infection, necessitating prompt and effective haemodynamic support. This review provides a comprehensive overview of current strategies for vasopressor and fluid management in septic shock, with the aim to optimize patient outcomes. With regard to vasopressor management, we elaborate on the pharmacologic profiles and clinical applications of catecholamines, vasopressin derivatives, angiotensin II, and other vasoactive agents. Noradrenaline remains central to septic shock management. The addition of vasopressin, when sequentially added to noradrenaline, offers a non-catecholaminergic vasoactive effect with some clinical benefits and risks of adverse effects. Emerging agents such as angiotensin II and hydroxocobalamin are highlighted for their roles in catecholamine-resistant vasodilatory shock. Next, for fluid management, crystalloids are currently preferred for initial resuscitation, with balanced crystalloids showing benefits over saline. The application of albumin in septic shock warrants further research. High-quality evidence does not support large-volume fluid resuscitation, and an individualized strategy based on haemodynamic parameters, including lactate clearance and capillary refill time, is recommended. The existing knowledge suggests that early vasopressor initiation, particularly noradrenaline, may be critical in cases where fluid resuscitation takes inadequate effect. Management of refractory septic shock remains challenging, with novel agents like angiotensin II and methylene blue showing potential in recent studies. In conclusion, Further research is needed to optimize haemodynamic management of septic shock, particularly in developing novel vasopressor usage and fluid management approaches.<\/jats:p>","DOI":"10.1093\/burnst\/tkae081","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T07:28:59Z","timestamp":1732778939000},"source":"Crossref","is-referenced-by-count":16,"title":["Haemodynamic management of septic shock"],"prefix":"10.1093","volume":"13","author":[{"given":"Yuki","family":"Kotani","sequence":"first","affiliation":[{"name":"Department of Intensive Care, Kameda Medical Center , 929 Higashi-cho, Kamogawa City, Chiba 296-8602,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Ryan","sequence":"additional","affiliation":[{"name":"Department of Intensive Care & Hyperbaric Medicine, The Alfred , 55 Commercial Rd, Melbourne VIC 3004,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A","family":"Udy","sequence":"additional","affiliation":[{"name":"Department of Intensive Care & Hyperbaric Medicine, The Alfred , 55 Commercial Rd, Melbourne VIC 3004,","place":["Australia"]},{"name":"Australian and New Zealand Intensive Care\u2014Research Centre, Monash University School of Public Health and Preventive Medicine , 553 St Kilda Road, Melbourne VIC 3004,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3854-4081","authenticated-orcid":false,"given":"Tomoko","family":"Fujii","sequence":"additional","affiliation":[{"name":"Australian and New Zealand Intensive Care\u2014Research Centre, Monash University School of Public Health and Preventive Medicine , 553 St Kilda Road, Melbourne VIC 3004,","place":["Australia"]},{"name":"Department of Intensive Care, Jikei University Hospital , 3-19-18, Nishi-Shinbashi, Minato-ku, Tokyo 105-8471,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"2025073002472886600_ref1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1164\/rccm.202311-2086SO","article-title":"From ICU syndromes to ICU subphenotypes: consensus report and recommendations for developing precision medicine in the ICU","volume":"210","author":"Gordon","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2025073002472886600_ref3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1378\/chest.12-1106","article-title":"Survival after shock requiring high-dose vasopressor therapy","volume":"143","author":"Brown","year":"2013","journal-title":"Chest"},{"key":"2025073002472886600_ref4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S0140-6736(07)61344-0","article-title":"Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial","volume":"370","author":"Annane","year":"2007","journal-title":"Lancet"},{"key":"2025073002472886600_ref5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/bcp.14969","article-title":"Dose equivalence between metaraminol and norepinephrine in critical care","volume":"88","author":"Abu Sardaneh","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2025073002472886600_ref8","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1007\/s00134-020-06216-x","article-title":"Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial","volume":"46","author":"Santer","year":"2020","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jcrc.2021.11.004","article-title":"A pilot, feasibility, randomised controlled trial of midodrine as adjunctive vasopressor for low-dose vasopressor-dependent hypotension in intensive care patients: the MAVERIC study","volume":"67","author":"Costa-Pinto","year":"2022","journal-title":"J Crit Care"},{"key":"2025073002472886600_ref10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"2025073002472886600_ref11","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1001\/jama.2019.14607","article-title":"Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial","volume":"322","author":"Laterre","year":"2019","journal-title":"JAMA"},{"key":"2025073002472886600_ref12","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1007\/s00134-018-5267-9","article-title":"Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial","volume":"44","author":"Liu","year":"2018","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of Vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13054-023-04397-7","article-title":"Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial","volume":"27","author":"Ibarra-Estrada","year":"2023","journal-title":"Crit Care"},{"key":"2025073002472886600_ref15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.chest.2022.09.021","article-title":"High-dose intravenous Hydroxocobalamin (vitamin B12) in septic shock: a double-blind, allocation-concealed, placebo-controlled single-Center pilot randomized controlled trial (the IV-HOCSS trial)","volume":"163","author":"Patel","year":"2022","journal-title":"Chest"},{"key":"2025073002472886600_ref16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref17","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref18","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1097\/CCM.0b013e318260c6c3","article-title":"Effects of norepinephrine on mean systemic pressure and venous return in human septic shock","volume":"40","author":"Persichini","year":"2012","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/CCM.0b013e318206d2a3","article-title":"Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients","volume":"39","author":"Monnet","year":"2011","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref20","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1097\/CCM.0000000000005885","article-title":"Immediate norepinephrine in Endotoxic shock: effects on regional and microcirculatory flow","volume":"51","author":"Ospina-Tasc\u00f3n","year":"2023","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13054-022-03911-7","article-title":"Vasopressor choice and timing in Vasodilatory shock","volume":"26","author":"Wieruszewski","year":"2022","journal-title":"Crit Care"},{"key":"2025073002472886600_ref22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.chest.2022.07.018","article-title":"The relationship between norepinephrine equivalent dose of vasopressors within 24 hours from the onset of septic shock and In-hospital mortality rate","volume":"163","author":"Sato","year":"2023","journal-title":"Chest"},{"key":"2025073002472886600_ref23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13613-017-0261-x","article-title":"Outcome of patients with septic shock and high-dose vasopressor therapy","volume":"7","author":"Auchet","year":"2017","journal-title":"Ann Intensive Care"},{"key":"2025073002472886600_ref24","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1053\/j.jvca.2023.05.013","article-title":"Norepinephrine dose should be reported as base equivalence in clinical research manuscripts","volume":"37","author":"Kotani","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025073002472886600_ref25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","article-title":"Position paper on the reporting of norepinephrine formulations in critical care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force","volume":"52","author":"Wieruszewski","year":"2024","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13054-023-04404-x","article-title":"Response to: norepinephrine formulation for equivalent vasopressive score","volume":"27","author":"Kotani","year":"2023","journal-title":"Crit Care"},{"key":"2025073002472886600_ref27","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00134-022-06652-x","article-title":"Dose of norepinephrine: the devil is in the details","volume":"48","author":"Leone","year":"2022","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/FJC.0000000000000682","article-title":"Low-dose adrenaline reduces blood pressure acutely in anesthetized pigs through a beta2-adrenergic pathway","volume":"74","author":"Lubberding","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"2025073002472886600_ref29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13613-019-0501-3","article-title":"The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis","volume":"9","author":"Cui","year":"2019","journal-title":"Ann Intensive Care"},{"key":"2025073002472886600_ref30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00134-024-07411-w","article-title":"Serial lactate measurements to guide resuscitation: more evidence not to?","volume":"50","author":"Legrand","year":"2024","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref31","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","article-title":"A comparison of epinephrine and norepinephrine in critically ill patients","volume":"34","author":"Myburgh","year":"2008","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref32","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(00)03495-4","article-title":"Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and new Zealand Intensive Care Society (ANZICS) clinical trials group","volume":"356","author":"Bellomo","year":"2000","journal-title":"Lancet"},{"key":"2025073002472886600_ref33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/CCM.0b013e31823778ee","article-title":"Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*","volume":"40","author":"De Backer","year":"2012","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref34","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1186\/cc7121","article-title":"Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial","volume":"12","author":"Morelli","year":"2008","journal-title":"Crit Care"},{"key":"2025073002472886600_ref35","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2017.2841","article-title":"Association between US norepinephrine shortage and mortality among patients with septic shock","volume":"317","author":"Vail","year":"2017","journal-title":"JAMA"},{"key":"2025073002472886600_ref36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.7326\/0003-4819-59-3-297","article-title":"Studies on the mechanism of action of Metaraminol (Aramine)","volume":"59","author":"Harrison","year":"1963","journal-title":"Ann Intern Med"},{"key":"2025073002472886600_ref37","doi-asserted-by":"publisher","first-page":"154430","DOI":"10.1016\/j.jcrc.2023.154430","article-title":"Dose equivalence for metaraminol and noradrenaline - a retrospective analysis","volume":"80","author":"Costa-Pinto","year":"2024","journal-title":"J Crit Care"},{"key":"2025073002472886600_ref38","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s00134-005-2607-3","article-title":"Norepinephrine and metaraminol in septic shock: a comparison of the hemodynamic effects","volume":"31","author":"Natalini","year":"2005","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref39","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"key":"2025073002472886600_ref40","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"key":"2025073002472886600_ref41","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","article-title":"Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials","volume":"45","author":"Nagendran","year":"2019","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13054-017-1798-7","article-title":"Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients","volume":"21","author":"Russell","year":"2017","journal-title":"Crit Care"},{"key":"2025073002472886600_ref43","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00134-007-0946-y","article-title":"Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis","volume":"34","author":"Lange","year":"2008","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref44","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care"},{"key":"2025073002472886600_ref45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0006-2952(93)90072-5","article-title":"Inhibition of nitric oxide synthesis by methylene blue","volume":"45","author":"Mayer","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"2025073002472886600_ref46","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/0310057X0203000606","article-title":"The influence of methylene blue infusion on cytokine levels during severe sepsis","volume":"30","author":"Memis","year":"2002","journal-title":"Anaesth Intensive Care"},{"key":"2025073002472886600_ref47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.niox.2010.01.006","article-title":"A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock","volume":"22","author":"Juffermans","year":"2010","journal-title":"Nitric Oxide"},{"key":"2025073002472886600_ref48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1053\/j.jvca.2015.09.011","article-title":"The blue coma: the role of methylene blue in unexplained coma after cardiac surgery","volume":"30","author":"Martino","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025073002472886600_ref49","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1164\/ajrccm.161.6.9812004","article-title":"Effects of nitric oxide in septic shock","volume":"161","author":"Vincent","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2025073002472886600_ref50","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.4049\/jimmunol.181.6.4320","article-title":"Endogenous hydrogen sulfide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis","volume":"181","author":"Zhang","year":"2008","journal-title":"J Immunol"},{"key":"2025073002472886600_ref51","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1053\/j.jvca.2023.03.017","article-title":"Seeing red: Hydroxocobalamin and result interference","volume":"37","author":"Ortoleva","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025073002472886600_ref52","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00068-023-02388-5","article-title":"Traumatic inflammatory response: pathophysiological role and clinical value of cytokines","volume":"50","author":"Li","year":"2023","journal-title":"Eur J Trauma Emerg Surg"},{"key":"2025073002472886600_ref53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.addr.2017.09.019","article-title":"The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: an appraisal utilizing antibiotics","volume":"123","author":"Udy","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"2025073002472886600_ref54","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/ALN.0000000000002314","article-title":"Early hemodynamic Management of Critically ill burn patients","volume":"129","author":"Soussi","year":"2018","journal-title":"Anesthesiology"},{"key":"2025073002472886600_ref55","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s13054-014-0538-5","article-title":"Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx","volume":"18","author":"Chappell","year":"2014","journal-title":"Crit Care"},{"key":"2025073002472886600_ref56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jcrc.2016.10.008","article-title":"Fluid resuscitation mediates the association between inhalational burn injury and acute kidney injury in the major burn population","volume":"38","author":"Kumar","year":"2017","journal-title":"J Crit Care"},{"key":"2025073002472886600_ref57","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/cc6916","article-title":"A positive fluid balance is associated with a worse outcome in patients with acute renal failure","volume":"12","author":"Payen","year":"2008","journal-title":"Crit Care"},{"key":"2025073002472886600_ref58","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1186\/cc12544","article-title":"Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients","volume":"17","author":"Udy","year":"2013","journal-title":"Crit Care"},{"key":"2025073002472886600_ref59","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0305-4179(99)00086-8","article-title":"Progression of burn wound depth by systemical application of a vasoconstrictor: an experimental study with a new rabbit model","volume":"25","author":"Knabl","year":"1999","journal-title":"Burns"},{"key":"2025073002472886600_ref60","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/aas.14095","article-title":"Vasoactive and\/or inotropic drugs in initial resuscitation of burn injuries: a systematic review","volume":"66","author":"Knappskog","year":"2022","journal-title":"Acta Anaesthesiol Scand"},{"key":"2025073002472886600_ref61","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00134-010-2117-9","article-title":"The crystalloid versus hydroxyethyl starch trial: protocol for a multi-Centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130\/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality","volume":"37","author":"Crystalloid versus Hydroxyethyl Starch Trial Management C","year":"2011","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref62","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus Ringer's acetate in severe sepsis","volume":"367","author":"Perner","year":"2012","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref63","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa040232","article-title":"A comparison of albumin and saline for fluid resuscitation in the intensive care unit","volume":"350","author":"Finfer","year":"2004","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref64","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00134-010-2039-6","article-title":"Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis","volume":"37","author":"Investigators","year":"2011","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref65","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref66","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/aas.14479","article-title":"Preferences for albumin use in adult intensive care unit patients with shock: an international survey","volume":"68","author":"Sivapalan","year":"2024","journal-title":"Acta Anaesthesiol Scand"},{"key":"2025073002472886600_ref67","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1164\/rccm.201903-0557OC","article-title":"Balanced crystalloids versus saline in sepsis. A secondary analysis of the SMART clinical trial","volume":"200","author":"Brown","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2025073002472886600_ref68","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1097\/CCM.0000000000000305","article-title":"Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*","volume":"42","author":"Raghunathan","year":"2014","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref69","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100010","article-title":"Balanced crystalloids versus saline in critically ill adults - a systematic review with meta-analysis","volume":"1","author":"Hammond","year":"2022","journal-title":"NEJM Evid"},{"key":"2025073002472886600_ref70","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref71","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/bja\/aex163","article-title":"Effects of intraoperative and early postoperative normal saline or plasma-Lyte 148(R) on hyperkalaemia in deceased donor renal transplantation: a double-blind randomized trial","volume":"119","author":"Weinberg","year":"2017","journal-title":"Br J Anaesth"},{"key":"2025073002472886600_ref72","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/08860220802064770","article-title":"Effects of normal saline vs. lactated ringer's during renal transplantation","volume":"30","author":"Khajavi","year":"2008","journal-title":"Ren Fail"},{"key":"2025073002472886600_ref73","doi-asserted-by":"publisher","first-page":"F152","DOI":"10.1152\/ajprenal.1989.256.1.F152","article-title":"Intrarenal vasoconstriction during hyperchloremia: role of thromboxane","volume":"256","author":"Bullivant","year":"1989","journal-title":"Am J Phys"},{"key":"2025073002472886600_ref74","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1172\/JCI110820","article-title":"Regulation of renal blood flow by plasma chloride","volume":"71","author":"Wilcox","year":"1983","journal-title":"J Clin Invest"},{"key":"2025073002472886600_ref75","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)31080-8","article-title":"Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial","volume":"392","author":"Jaber","year":"2018","journal-title":"Lancet"},{"key":"2025073002472886600_ref76","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1097\/CCM.0000000000005955","article-title":"Sodium bicarbonate for metabolic acidosis in the ICU: results of a pilot randomized double-blind clinical trial","volume":"51","author":"Serpa Neto","year":"2023","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref77","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1056\/NEJMoa2212663","article-title":"Early restrictive or liberal fluid Management for Sepsis-Induced Hypotension","volume":"388","author":"National Heart L, Blood Institute P","year":"2023","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref78","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.chest.2019.11.050","article-title":"Lower vs higher fluid volumes during initial Management of Sepsis: a systematic review with meta-analysis and trial sequential analysis","volume":"157","author":"Meyhoff","year":"2020","journal-title":"Chest"},{"key":"2025073002472886600_ref79","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/01.CCM.0000194725.48928.3A","article-title":"Sepsis in European intensive care units: results of the SOAP study","volume":"34","author":"Vincent","year":"2006","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref80","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis","volume":"46","author":"Fleischmann-Struzek","year":"2020","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref81","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1097\/CCM.0b013e31828a25fd","article-title":"Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense","volume":"41","author":"Marik","year":"2013","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref82","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/01.CCM.0000114996.68110.C9","article-title":"Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects","volume":"32","author":"Kumar","year":"2004","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref83","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/0885066617752308","article-title":"Accuracy of Ultrasonographic measurements of inferior vena cava to determine fluid responsiveness: a systematic review and meta-analysis","volume":"35","author":"Orso","year":"2020","journal-title":"J Intensive Care Med"},{"key":"2025073002472886600_ref84","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s00134-015-4134-1","article-title":"Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis","volume":"42","author":"Monnet","year":"2016","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref85","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.chest.2020.04.025","article-title":"Fluid response evaluation in sepsis hypotension and shock: a randomized clinical trial","volume":"158","author":"Douglas","year":"2020","journal-title":"Chest"},{"key":"2025073002472886600_ref86","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1164\/ajrccm.162.1.9903035","article-title":"Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure","volume":"162","author":"Michard","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2025073002472886600_ref87","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1097\/CCM.0b013e3181a590da","article-title":"Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature","volume":"37","author":"Marik","year":"2009","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref88","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s00134-015-3955-2","article-title":"Early lactate clearance-guided therapy in patients with sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials","volume":"41","author":"Gu","year":"2015","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref89","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2019.0071","article-title":"Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial","volume":"321","author":"Hernandez","year":"2019","journal-title":"JAMA"},{"key":"2025073002472886600_ref90","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref91","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1056\/NEJMoa1701380","article-title":"Early, goal-directed therapy for septic shock - a patient-level meta-analysis","volume":"376","author":"Investigators","year":"2017","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref92","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/cc13868","article-title":"Timing of vasopressor initiation and mortality in septic shock: a cohort study","volume":"18","author":"Beck","year":"2014","journal-title":"Crit Care"},{"key":"2025073002472886600_ref93","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s13054-014-0532-y","article-title":"Early versus delayed administration of norepinephrine in patients with septic shock","volume":"18","author":"Bai","year":"2014","journal-title":"Crit Care"},{"key":"2025073002472886600_ref94","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1164\/rccm.201806-1034OC","article-title":"Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial","volume":"199","author":"Permpikul","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2025073002472886600_ref95","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/1742-6723.13406","article-title":"Safety of peripheral administration of vasopressor medications: a systematic review","volume":"32","author":"Tian","year":"2020","journal-title":"Emerg Med Australas"},{"key":"2025073002472886600_ref96","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1097\/00003246-200008000-00012","article-title":"Effect of norepinephrine on the outcome of septic shock","volume":"28","author":"Martin","year":"2000","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref97","doi-asserted-by":"publisher","first-page":"e0129305","DOI":"10.1371\/journal.pone.0129305","article-title":"Vasopressors for the treatment of septic shock: systematic review and meta-analysis","volume":"10","author":"Avni","year":"2015","journal-title":"PLoS One"},{"key":"2025073002472886600_ref98","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2110-5820-1-6","article-title":"Septic cardiomyopathy","volume":"1","author":"Vieillard-Baron","year":"2011","journal-title":"Ann Intensive Care"},{"key":"2025073002472886600_ref99","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","article-title":"Levosimendan for the prevention of acute organ dysfunction in sepsis","volume":"375","author":"Gordon","year":"2016","journal-title":"N Engl J Med"},{"key":"2025073002472886600_ref100","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","article-title":"Association of Catecholamine Dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock","volume":"50","author":"Sacha","year":"2022","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref101","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA"},{"key":"2025073002472886600_ref102","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.2023.20134","article-title":"Landiolol and organ failure in patients with septic shock: the STRESS-L randomized clinical trial","volume":"330","author":"Whitehouse","year":"2023","journal-title":"JAMA"},{"key":"2025073002472886600_ref103","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving sepsis campaign international guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in children","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"2025073002472886600_ref104","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00134-012-2468-5","article-title":"Recommendations for sepsis management in resource-limited settings","volume":"38","author":"Dunser","year":"2012","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref105","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant Vasodilatory shock. A clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2025073002472886600_ref106","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1213\/ANE.0000000000006682","article-title":"Renin as a prognostic marker in intensive care and perioperative settings: a scoping review","volume":"138","author":"Kotani","year":"2024","journal-title":"Anesth Analg"},{"key":"2025073002472886600_ref107","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/CCM.0000000000006314","article-title":"Low versus high blood pressure targets in critically ill and surgical patients: a systematic review and meta-analysis of randomized controlled trials","volume":"52","author":"D'Amico","year":"2024","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref108","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jama.2020.0930","article-title":"Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with Vasodilatory hypotension: a randomized clinical trial","volume":"323","author":"Lamontagne","year":"2020","journal-title":"JAMA"},{"key":"2025073002472886600_ref109","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1164\/rccm.201912-2316OC","article-title":"Relative hypotension and adverse kidney-related outcomes among critically ill patients with shock. A Multicenter, prospective cohort study","volume":"202","author":"Panwar","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2025073002472886600_ref110","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13054-018-2144-4","article-title":"Refractory septic shock: our pragmatic approach","volume":"22","author":"Nandhabalan","year":"2018","journal-title":"Crit Care"},{"key":"2025073002472886600_ref111","doi-asserted-by":"publisher","first-page":"154258","DOI":"10.1016\/j.jcrc.2023.154258","article-title":"Refractory septic shock and alternative wordings: a systematic review of literature","volume":"75","author":"Antonucci","year":"2023","journal-title":"J Crit Care"},{"key":"2025073002472886600_ref112","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with Vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref113","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/j.jvca.2023.09.037","article-title":"Methylene blue reduces mortality in critically ill and perioperative patients: a meta-analysis of randomized trials","volume":"38","author":"Pruna","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2025073002472886600_ref114","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1590\/S0100-879X1999001200009","article-title":"Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue","volume":"32","author":"Weingartner","year":"1999","journal-title":"Braz J Med Biol Res"},{"key":"2025073002472886600_ref115","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/BF01700666","article-title":"Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock","volume":"21","author":"Gachot","year":"1995","journal-title":"Intensive Care Med"},{"key":"2025073002472886600_ref116","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","article-title":"Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study","volume":"29","author":"Kirov","year":"2001","journal-title":"Crit Care Med"},{"key":"2025073002472886600_ref117","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2110-5820-1-7","article-title":"Corticosteroids for severe sepsis: an evidence-based guide for physicians","volume":"1","author":"Annane","year":"2011","journal-title":"Ann Intensive Care"},{"key":"2025073002472886600_ref118","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002243.pub4","article-title":"Corticosteroids for treating sepsis in children and adults","author":"Annane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2025073002472886600_ref119","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300034","article-title":"Patient-level meta-analysis of low-dose hydrocortisone in adults with septic shock","volume":"2","author":"Pirracchio","year":"2023","journal-title":"NEJM Evid"},{"key":"2025073002472886600_ref120","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"}],"container-title":["Burns &amp; Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/burnstrauma\/article-pdf\/doi\/10.1093\/burnst\/tkae081\/61443130\/tkae081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/burnstrauma\/article-pdf\/doi\/10.1093\/burnst\/tkae081\/61443130\/tkae081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T06:47:36Z","timestamp":1753858056000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/burnstrauma\/article\/doi\/10.1093\/burnst\/tkae081\/7954519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":120,"URL":"https:\/\/doi.org\/10.1093\/burnst\/tkae081","relation":{},"ISSN":["2321-3876"],"issn-type":[{"value":"2321-3876","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"tkae081"}}